GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $791,000 | -17.9% | 3,647 | -56.3% | 0.00% | -20.0% |
| Q4 2020 | $963,000 | +8.7% | 8,347 | -8.3% | 0.01% | 0.0% |
| Q3 2020 | $886,000 | -17.4% | 9,105 | +4.2% | 0.01% | -28.6% |
| Q2 2020 | $1,073,000 | +22.8% | 8,741 | -12.4% | 0.01% | 0.0% |
| Q1 2020 | $874,000 | -33.1% | 9,977 | -20.2% | 0.01% | -22.2% |
| Q4 2019 | $1,307,000 | +26.0% | 12,497 | +38.6% | 0.01% | +12.5% |
| Q3 2019 | $1,037,000 | -41.8% | 9,014 | -12.8% | 0.01% | -42.9% |
| Q2 2019 | $1,781,000 | +87.3% | 10,333 | +83.1% | 0.01% | +75.0% |
| Q1 2019 | $951,000 | +303.0% | 5,642 | +233.6% | 0.01% | +300.0% |
| Q2 2018 | $236,000 | +5.4% | 1,691 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $224,000 | -65.5% | 1,694 | -73.5% | 0.00% | -71.4% |
| Q3 2017 | $650,000 | – | 6,401 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |